Acadia Pharmaceuticals | Créanciers Commerciaux



Trade Creditors Changement Date
Acadia Pharmaceuticals USD 18.1M 1.9M 2025-03
ALKERMES USD 59.84M 14.21M 2025-03
Alnylam Pharmaceuticals USD 97.4M 8.98M 2025-03
Biogen USD 391.5M 32.7M 2025-03
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Bristol-Myers Squibb USD 4B 400M 2025-03
Corcept Therapeutics USD 15.38M 3.21M 2024-12
Cytokinetics USD 20.37M 8.79M 2024-12
Eisai JPY 64.53B 1.79B 2024-12
Eli Lilly USD 3.44B 213.4M 2025-03
Incyte USD 195.54M 1.93M 2025-03
J&J USD 9.54B 766M 2025-03
Moderna USD 226M 179M 2025-03
Neurocrine Biosciences 110M 282.7M 2024-12
Pfizer USD 5.24B 393M 2025-03
Prothena USD 7.77M 2.56M 2024-12
PTC Therapeutics USD 15.15M 2.12M 2025-03
Sarepta Therapeutics USD 156.1M 58.34M 2025-03
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12



Acadia Pharmaceuticals Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.